Hoya Corp (HOCPY)
113.68
+0.32
(+0.28%)
USD |
OTCM |
Apr 18, 16:00
Hoya Revenue (TTM): 5.537B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.537B |
| September 30, 2023 | 5.429B |
| June 30, 2023 | 5.420B |
| March 31, 2023 | 5.438B |
| December 31, 2022 | 5.496B |
| September 30, 2022 | 5.762B |
| June 30, 2022 | 5.913B |
| March 31, 2022 | 5.965B |
| December 31, 2021 | 5.915B |
| September 30, 2021 | 5.831B |
| June 30, 2021 | 5.667B |
| March 31, 2021 | 5.271B |
| December 31, 2020 | 5.079B |
| September 30, 2020 | 5.008B |
| June 30, 2020 | 5.122B |
| March 31, 2020 | 5.360B |
| December 31, 2019 | 5.410B |
| September 30, 2019 | 5.335B |
| June 30, 2019 | 5.177B |
| March 31, 2019 | 5.163B |
| December 31, 2018 | 5.124B |
| September 30, 2018 | 5.071B |
| June 30, 2018 | 5.011B |
| March 31, 2018 | 4.883B |
| December 31, 2017 | 4.740B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.644B |
| June 30, 2017 | 4.604B |
| March 31, 2017 | 4.526B |
| December 31, 2016 | 4.481B |
| September 30, 2016 | 4.406B |
| June 30, 2016 | 4.321B |
| March 31, 2016 | 4.292B |
| December 31, 2015 | 4.304B |
| September 30, 2015 | 4.374B |
| June 30, 2015 | 4.445B |
| March 31, 2015 | 4.516B |
| December 31, 2014 | 4.563B |
| September 30, 2014 | 4.553B |
| June 30, 2014 | 4.424B |
| March 31, 2014 | 4.337B |
| December 31, 2013 | 4.425B |
| September 30, 2013 | 4.456B |
| June 30, 2013 | 4.684B |
| March 31, 2013 | 4.984B |
| December 31, 2012 | 4.870B |
| September 30, 2012 | 5.005B |
| June 30, 2012 | 5.028B |
| December 31, 2011 | 5.026B |
| September 30, 2011 | 5.180B |
| June 30, 2011 | 5.177B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.008B
Minimum
Sep 2020
5.965B
Maximum
Mar 2022
5.481B
Average
5.429B
Median
Sep 2023
Revenue (TTM) Benchmarks
| Takeda Pharmaceutical Co Ltd | 29.70B |
| Nxera Pharma Co Ltd | 88.33M |
| PeptiDream Inc | 202.69M |
| Stemcell Holdings Inc | 9.984M |
| Healios KK | 0.8776M |